NewGenIvf (NIVF) Receivables (2022 - 2025)

NewGenIvf has disclosed Receivables across 4 years of filings, most recently posting $276763.0 for Q4 2025.

• In Q4 2025, Receivables fell 39.01% year-over-year to $276763.0; the TTM figure through Dec 2025 stood at $276763.0 (down 39.01% YoY), while the FY2025 annual figure was $276763.0, down 39.01% from the prior year.
• Receivables slipped to $276763.0 in Q4 2025, from $275.9 billion in the prior quarter.
• Over the last five years, Receivables for NIVF reached as high as $275.9 billion in Q3 2025 and fell as low as $33728.0 in Q4 2023.
• The 4-year median for Receivables is $361508.5 (2025), against an average of $46.0 billion.
• Annual changes were most pronounced in 2024 — Receivables jumped 1245.51% — and 2025, when it plunged 39.01%.
• A 4-year view of Receivables shows it stood at $43295.0 in 2022, then retreated by 22.1% to $33728.0 in 2023, then jumped by 1245.51% to $453813.0 in 2024, then sank by 39.01% to $276763.0 in 2025.
• According to Business Quant data, Receivables over the past three periods registered $276763.0, $275.9 billion, and $446254.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.